We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

AusPAR: Adalimumab

Australian Public Assessment Report

AusPAR

AusPAR Adalimumab [PDF, 1023.41 KB]

AusPAR Adalimumab [Word, 1.25 MB]

Attachment: Product Information Adalimumab [PDF, 642.86 KB]

Attachment: Product Information Adalimumab [Word, 388.31 KB]

Attachment: Extract from Clinical Evaluation Report: Adalimumab [PDF, 2.93 MB]

Attachment: Extract from Clinical Evaluation Report: Adalimumab [Word, 5.35 MB]

Device/Product Name

Humira

Active ingredients

Adalimumab

AusPAR Date

20 March 2017

Published

12 April 2017

Submission Number

PM-2015-01149-1-3

Submission Type

Extension of indications

Decision

Approved